Conclusions
The primary workup of a patient with an undiagnosed pelvic mass includes a history and physical examination, ultrasonography, serum CA-125 or other appropriate tumor markers in selected patients, chest radiography, and serum liver chemistries. Additional studies such as CT, colonoscopy, or upper gastrointestinal imaging may be performed when clinically warranted. If the operative evaluation of a pelvic mass reveals an ovarian carcinoma, comprehensive staging and TAH/BSO is recommended. Young patients who want to retain childbearing capacity and have low grade, low stage tumors can undergo unilateral salpingo-oophorectomy with comprehensive staging. If the patient clinically has Stage III or IV disease, cytoreductive surgery is recommended. Chemotherapy is based on tumor histology, stage, and grade.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Morrow CP, Curtin JP, Townsend DE. Tumors of the ovary: the adnexal mass. In: Morrow CP, Curtin JP, Townsend DE (eds) Synopsis of Gynecologic Oncology, 4th ed. New York: Churchill Livingstone, 1993; 215–232.
American College of Obstetricians and Gynecologists. Cancer of the Ovary. Technical Bulletin 141. Washington, DC: ACOG, 1990.
DePriest PD, Puls LE, Schwartz RW, et al. Metastatic gastric cancer presenting as a pelvic mass. J Ky Med Assoc 1993;91:193–194.
DePriest PD, Gallion HH, Pavlik EJ, et al. Transvaginal sonography as a screening method for the detection of early ovarian cancer. Gynecol Oncol 1997;65:408–414.
DePriest PD, van Nagell JR, Gallion HH, et al. Ovarian cancer screening in asymptomatic postmenopausal women. Gynecol Oncol 1993;51:205–209.
FIGO. Staging announcement: FIGO Cancer Committee. Gynecol Oncol 1986;25:383.
Malkasian GD, Knapp RC, Lavin PT, et al. Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease. Am J Obstet Gynecol 1988;159:341–346.
Goldstein SR, Subramanyam B, Snyder JR, et al. The postmenopausal cystic adnexal mass: the potential role of ultrasound in conservative management. Obstet Gynecol 1989;38:8–10.
American College of Obstetricians and Gynecologists. Ovarian Cystectomy. Criteria Set 24. Washington, DC: ACOG, 1996.
Berek JS, Hacker NF. Nonepithelial ovarian and fallopian tube cancers. In: Berek JS, Hacker NF (eds) Practical Gynecologic Oncology, 2nd ed. Baltimore: Williams & Wilkins, 1994;377–402.
Hoskins WJ, McGuire WP, Brady MF, et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994;170:974–979.
Venesmaa P, Ylikorkala O. Morbidity and mortality associated with primary and repeat operations for ovarian cancer. Obstet Gynecol 1992;79:162–172.
NIH Consensus Development Conference on Ovarian Cancer: Screening, treatment, and follow-up. Gynecol Oncol 1994;55:S173.
Goodman HM, Harlow BL, Sheets EE, et al. The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinoma. Gynecol Oncol 1992;46:367–371.
Ozols RF, Rubin SC, Thomas G, et al. Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC (eds) Principles and Practice of Gynecologic Oncology, 2nd ed. Philadelphia: Lippincott-Raven, 1997;919–986.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Welshinger, M. (2003). Adnexal Masses. In: Saclarides, T.J., Millikan, K.W., Godellas, C.V. (eds) Surgical Oncology. Springer, New York, NY. https://doi.org/10.1007/0-387-21701-0_74
Download citation
DOI: https://doi.org/10.1007/0-387-21701-0_74
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-95201-7
Online ISBN: 978-0-387-21701-7
eBook Packages: Springer Book Archive